CANC vs FAAR
Comparison between Tema Oncology ETF (CANC, ETF) and FIRST TRUST ALTERNATIVE ABSOLUTE RETURN STRATEGY ETF (FAAR, ETF).
5-Year PerformanceFAAR has outperformed CANC, delivering a return of +7.5% compared to -9.4%
CANC vs FAAR - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
CANC vs FAAR - Holdings Comparison
CANC and FAAR have 0 common holdings. Overlap is 0.00%
CANC's top 25 holdings weight is 76.89%. FAAR's top 25 holdings weight is 16.37%.
| Rank | CANC | FAAR |
|---|---|---|
| #1 | REVOLUTION MEDICINES INC ORDINARY SHARES (RVMD) - 7.31% | MORGAN STANLEY INSTL LQUDTY TRS INSTL (MISXX) - 16.37% |
| #2 | ELI LILLY AND CO (LLY) - 4.25% | N/A |
| #3 | IMMUNOME INC ORDINARY SHARES (IMNM) - 4.21% | N/A |
| #4 | COGENT BIOSCIENCES INC (COGT) - 4.08% | N/A |
| #5 | ROCHE HOLDING AG ADR (RHHBY) - 4.07% | N/A |
| #6 | NOVARTIS AG REGISTERED SHARES (n/a) - 4.00% | N/A |
| #7 | CELCUITY INC (CELC) - 3.93% | N/A |
| #8 | ASTRAZENECA PLC (AZN:XLON) - 3.50% | N/A |
| #9 | MERCK & CO INC (MRK) - 3.43% | N/A |
| #10 | BRISTOL-MYERS SQUIBB CO (BMY) - 3.34% | N/A |
| #11 | NUVALENT INC CLASS A (NUVL) - 3.15% | N/A |
| #12 | LEGEND BIOTECH CORP ADR (LEGN) - 2.94% | N/A |
| #13 | GENMAB AS ADR (GMAB) - 2.87% | N/A |
| #14 | ABBVIE INC (ABBV) - 2.70% | N/A |
| #15 | BRIDGEBIO PHARMA INC (BBIO) - 2.63% | N/A |
| #16 | CG ONCOLOGY INC (CGON) - 2.56% | N/A |
| #17 | JOHNSON & JOHNSON (JNJ) - 2.55% | N/A |
| #18 | ZAI LAB LTD ADR REPR 1 SHS (ZLAB) - 2.49% | N/A |
| #19 | EXELIXIS INC (EXEL) - 2.45% | N/A |
| #20 | IDEAYA BIOSCIENCES INC (IDYA) - 2.10% | N/A |
| #21 | AMGEN INC (AMGN) - 2.04% | N/A |
| #22 | BEONE MEDICINES LTD ADR (ONC) - 1.95% | N/A |
| #23 | ZYMEWORKS INC REGISTERED SHS (ZYME) - 1.62% | N/A |
| #24 | FIRST AMERICAN TREASURY OBLIGS X (FXFXX) - 1.47% | N/A |
| #25 | ANAPTYSBIO INC (ANAB) - 1.25% | N/A |
| Total Holdings | 57 | 1 |
CANC vs FAAR - Historical Returns
Returns include dividend reinvestment.
CANC vs FAAR - Annual Returns (2016 - 2026)
Returns include dividend reinvestment.
| Year | CANC | FAAR |
|---|---|---|
| 2026 | +8.37% | +22.25% |
| 2025 | +42.13% | +6.84% |
| 2024 | -6.11% | +5.74% |
| 2023 | +515.06% | -4.73% |
| 2022 | -85.58% | +10.10% |
| 2021 | -51.82% | +12.29% |
| 2020 | N/A | +11.07% |
| 2019 | N/A | -1.61% |
| 2018 | N/A | -8.92% |
| 2017 | N/A | +5.00% |
| 2016 | N/A | -3.78% |
CANC vs FAAR Drawdown Comparison
The maximum drawdown for CANC was -97.53%, occurring on Apr 5, 2023. This drawdown has not yet recovered.
The maximum drawdown for FAAR was -18.06%, occurring on Apr 8, 2025. Recovery took 901 trading sessions.
The current CANC drawdown is -55.25%. The current FAAR drawdown is -3.52%.
| Rank | CANC | FAAR |
|---|---|---|
| #1 | -97.53% Oct 20, 2021 - Apr 5, 2023 | -18.06% Jun 9, 2022 - Jan 13, 2026 |
| #2 | -16.18% Oct 5, 2021 - Oct 20, 2021 | -16.65% May 21, 2018 - Feb 22, 2021 |
| #3 | N/A | -12.20% Jul 13, 2021 - Feb 7, 2022 |
| #4 | N/A | -6.77% May 3, 2017 - Jan 11, 2018 |
| #5 | N/A | -6.33% Mar 8, 2022 - Jun 9, 2022 |
| #6 | N/A | -5.93% Jul 13, 2016 - May 3, 2017 |
| #7 | N/A | -5.87% Jun 8, 2021 - Jul 13, 2021 |
| #8 | N/A | -5.76% Jan 24, 2018 - May 21, 2018 |
| #9 | N/A | -3.63% Feb 24, 2021 - Apr 29, 2021 |
| #10 | N/A | -3.52% May 18, 2026 - Jun 9, 2026 |
| #11 | N/A | -2.88% Jan 29, 2026 - Feb 19, 2026 |
| #12 | N/A | -2.70% Mar 20, 2026 - Apr 2, 2026 |
| #13 | N/A | -2.24% Apr 30, 2026 - May 18, 2026 |
| #14 | N/A | -2.03% Feb 11, 2022 - Feb 22, 2022 |
| #15 | N/A | -1.98% Feb 23, 2022 - Mar 1, 2022 |
Correlation
Correlation between CANC and FAAR is 0.26 which considered as a very weak or no correlation - the stocks move independently of each other.
Dividend Comparison (2017 - 2026)
CANC vs FAAR dividend yield comparison.
| Year | CANC | FAAR |
|---|---|---|
| 2026 | 0.00% | 0.33% |
| 2025 | 0.06% | 11.63% |
| 2024 | 3.00% | 3.45% |
| 2023 | 0.56% | 3.20% |
| 2022 | 0.00% | 5.82% |
| 2021 | 0.00% | 6.49% |
| 2020 | 0.00% | 3.05% |
| 2019 | 0.00% | 1.02% |
| 2018 | 0.00% | 0.58% |
| 2017 | 0.00% | 2.83% |
Select Stocks to Compare
More Comparisons
Compare with similar stocks